2Edwards P,Blackshaw GR,Lewis WG,et al.Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma[J].Br J Cancer,2004,90(10):1888.
3Mochiki E,Kuwano H,Kamiyama Y,et al.Sentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinoma[J].Am J Surg,2006,191(4):465-469.
4笹子三津留.新癌の外科-手术手技シハへズ[J].胃癌,2002,1:23-34.
5Henk HH,Cornelis J H.Status of extended lymph node dissection:Locoregional control is the only way to survive gastric cancer[J].J Surg Oncol,2005,90:153-165.
6Mansfield PF.Lymphadenectomy for gastric cancer[J].J Clin Oncol,2004,22(14):2759-2761.
7Sano T,Sasako M,Yamamoto,et al.Gastric cancer surgery:Morbidity and mortality resulte from a prospective randomized conlrolled trail comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501[J].J Clin Oncol,2004,22(14):2761-2773.
8Gilly FN,Cotte E,Brigand C,et al.Quantitative prognostic indices in peritoneal carcinomatosis[J].EJSO,2006,32(6):591-601.
10Noh SH,Hyung WJ,Cheong J.H.Minimally invasive treatment for gastric cancer:approaches and selection process[J].J Surg Oncol,2005,90:188-190.
同被引文献2
1Ferlay J,Shin HR,Bray F,Forman D,Mathers C and Parkin DM. GLOBOCAN 2008,Cancer Incidence and Mortality Worldwide:IARC CancerBase No.10[Internet][R].Lyon,France:International Agency for Research on Cancer,2010.
